Live: Will Alphabet Smash Q2 Earnings Tonight After Berkshire Hathaway’s Big Bet?

Investing

Pfizer : PFE

All Pfizer Articles

1517 Articles

Paul Ausick | Nov 1, 2016 at 4:01 PM EDT

Apple, Pfizer Sink DJIA on Tuesday

November 1, 2016: Markets opened higher again Tuesday but drifted lower beginning in the mid-morning, and appear on track for…

Chris Lange | Nov 1, 2016 at 9:05 AM EDT

Why Pfizer Earnings Did Not Live Up to Expectations

As Pfizer is a major player in the pharmaceutical industry, this earnings report is important in setting a direction that…

Chris Lange | Oct 31, 2016 at 10:25 AM EDT

What to Expect From Pfizer Earnings

Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.

Chris Lange | Oct 30, 2016 at 10:05 AM EDT

8 Top Earnings for the Week Ahead

24/7 Wall St. has put together a preview of Pfizer, Starbucks and some of the major companies reporting their quarterly…

Chris Lange | Oct 26, 2016 at 7:40 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The October 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Lee Jackson | Oct 24, 2016 at 8:20 AM EDT

Bad Headlines and Huge Deals Put Top Dividend Stocks on Sale

Savvy investors know that often the best time to buy a stock, especially a solid company with a mature franchise,…

Trey Thoelcke | Oct 21, 2016 at 7:45 AM EDT

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even…

Jon C. Ogg | Oct 20, 2016 at 12:25 PM EDT

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

Americans generally would like to spend less money on health care. One way that this can be and will be…

Jon C. Ogg | Oct 18, 2016 at 1:10 PM EDT

5 Dow Stocks That Analysts Grossly Overestimated for 2016

It is very rare for a year to go exactly as analysts and investors might expect. After all, predicting a…

Paul Ausick | Oct 13, 2016 at 4:01 PM EDT

Chevron, Goldman Lead DJIA Thursday Decline

October 13, 2016: Markets opened lower Thursday following a weaker view on China’s trade balance joined with worries about the…

Chris Lange | Oct 12, 2016 at 7:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The September 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Paul Ausick | Oct 6, 2016 at 4:01 PM EDT

American Express, Wal-Mart Weigh on DJIA Thursday

October 6, 2016: Markets opened slightly lower Thursday and tracked close to the break-even line for much of the day.…

Paul Ausick | Sep 29, 2016 at 4:01 PM EDT

Goldman, Merck Lead DJIA Thursday Plunge

September 29, 2016: Markets opened slightly higher again Thursday following Wednesday’s announced agreement among OPEC members to rein in production.…

Chris Lange | Sep 27, 2016 at 7:40 AM EDT

Major Pharma Continues to See Rising Tide in Short Interest

The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Sep 26, 2016 at 4:01 PM EDT

Goldman Sachs, JPMorgan Sink DJIA Monday

September 26, 2016: Markets opened lower again Monday and only the recently added real-estate sector traded higher on the day.…

1 … 47 48 49 50 51 … 102

Pfizer : PFE

All Pfizer Articles

Apple, Pfizer Sink DJIA on Tuesday

Why Pfizer Earnings Did Not Live Up to Expectations

What to Expect From Pfizer Earnings

8 Top Earnings for the Week Ahead

Short Sellers Grow More Selective on Major Pharma Stocks

Bad Headlines and Huge Deals Put Top Dividend Stocks on Sale

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

5 Dow Stocks That Analysts Grossly Overestimated for 2016

Chevron, Goldman Lead DJIA Thursday Decline

Major Pharma Short Sellers Grow More Selective

American Express, Wal-Mart Weigh on DJIA Thursday

Goldman, Merck Lead DJIA Thursday Plunge

Major Pharma Continues to See Rising Tide in Short Interest

Goldman Sachs, JPMorgan Sink DJIA Monday

Live: Will Alphabet Smash Q2 Earnings Tonight After Berkshire Hathaway’s Big Bet?

Live: Will Tesla Crush Tonight’s Q2 Earnings After Big Delivery Volume Beat?

Live: Will ServiceNow’s Q2 Earnings Tonight Drive a Rebound After 38% YTD Decline?

‘You Have Far More Investment Choices’: Suze Orman to a Caller Trapped in a $114,000 Lump-Sum 401(k) Rollover

This 1 Momentum ETF Is Still Beating the S&P 500 With Lower Drawdowns

Chasing Yield Is a Trap. These 3 Dividend ETFs Pay You Without the Risk

'I Didn't Ask My Wife's Opinion About Anything. I Just Went and Did Whatever I Wanted': Dave Ramsey to a 29-Year-Old Groom on Building Generational Wealth

'You Have Far More Investment Choices': Suze Orman to a Caller Trapped in a $114,000 Lump-Sum 401(k) Rollover

‘I Didn’t Ask My Wife’s Opinion About Anything. I Just Went and Did Whatever I Wanted’: Dave Ramsey to a 29-Year-Old Groom on Building Generational Wealth

‘You Have Far More Investment Choices’: Suze Orman to a Caller Trapped in a $114,000 Lump-Sum 401(k) Rollover

Pfizer : PFE

All Pfizer Articles

Apple, Pfizer Sink DJIA on Tuesday

Why Pfizer Earnings Did Not Live Up to Expectations

What to Expect From Pfizer Earnings

8 Top Earnings for the Week Ahead

Short Sellers Grow More Selective on Major Pharma Stocks

Bad Headlines and Huge Deals Put Top Dividend Stocks on Sale

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

5 Dow Stocks That Analysts Grossly Overestimated for 2016

Chevron, Goldman Lead DJIA Thursday Decline

Major Pharma Short Sellers Grow More Selective

American Express, Wal-Mart Weigh on DJIA Thursday

Goldman, Merck Lead DJIA Thursday Plunge

Major Pharma Continues to See Rising Tide in Short Interest

Goldman Sachs, JPMorgan Sink DJIA Monday

Live: Will Alphabet Smash Q2 Earnings Tonight After Berkshire Hathaway’s Big Bet?

Live: Will Tesla Crush Tonight’s Q2 Earnings After Big Delivery Volume Beat?

Live: Will ServiceNow’s Q2 Earnings Tonight Drive a Rebound After 38% YTD Decline?

‘You Have Far More Investment Choices’: Suze Orman to a Caller Trapped in a $114,000 Lump-Sum 401(k) Rollover

This 1 Momentum ETF Is Still Beating the S&P 500 With Lower Drawdowns

Chasing Yield Is a Trap. These 3 Dividend ETFs Pay You Without the Risk

Featured Reads

'I Didn't Ask My Wife's Opinion About Anything. I Just Went and Did Whatever I Wanted': Dave Ramsey to a 29-Year-Old Groom on Building Generational Wealth

'You Have Far More Investment Choices': Suze Orman to a Caller Trapped in a $114,000 Lump-Sum 401(k) Rollover